|

The Pathogenesis and Prognostic Factors of Lymphoma

RECRUITINGSponsored by Shanghai Zhongshan Hospital
Actively Recruiting
SponsorShanghai Zhongshan Hospital
Started2023-06-05
Est. completion2027-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06203652

Summary

The aim of this study is to describe the clinical and genetic characteristics of Chinese lymphoma patients, and to explore the relationship between those characteristics and phatogenesis.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients with pathological diagnosis of lymphoma (including Hodgkin lymphoma and non-Hodgkin lyphoma, eg. THRLBCL, DLBCL, MZL, CLL/SLL...) from 2007 to 2027.
* Patients with complete diagnostic, treatment and follow-up records.
* Fully comprehension and signature of the informed consent form (ICF) for participation.

Exclusion Criteria:

* Those who refuse to use reliable methods of contraception during pregnancy, lactation or age-appropriate period.
* Severe mental illness.
* Patients deemed unsuitable for inclusion by the investigator.

Conditions4

CancerHodgkin LymphomaLymphomaNon-hodgkin Lymphoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.